Skip to main content
. 2017 Aug 3;8(51):88537–88551. doi: 10.18632/oncotarget.19877

Table 1. Descriptive characteristics of case and control subjects.

Variables Controls (n=50) BPH (n=48) P value
Median (95% CI) Median (95% CI)
Continuous variables
Age(years) 65.00(64.98-67.22) 69.00(67.97-70.86) 0.001*b
Height(cm) 1.70(1.70-1.73) 1.70(1.69-1.72) 0.923b
Weight(kg) 68.50(66.31-71.37) 75.00(71.71-76.79) 0.003*a
BMI(kg/m2) 23.60(22.57-24.39) 25.34(24.59-26.43) 0.002*a
FPG(mmol/L) 5.25(5.05-5.37) 5.05(4.96-5.25) 0.321a
SBP(mmHg) 124.50(120.70-126.87) 123.00(119.45-126.05) 0.581b
DBP(mmHg) 78.50(75.50-79.86) 76.50(73.51-78.37) 0.307b
PSA(ng/ml) 0.67(0.67-0.76) 2.83(2.77-4.30) <0.001*b
Total cholesterol(mmol/L) 3.92(3.80-4.24) 4.38(4.02-4.61) 0.11a
Triglycerides(mmol/L) 1.21(1.24-1.66) 1.26(1.20-1.63) 0.831b
LDL(mmol/L) 2.67(2.45-2.81) 2.88(2.70-3.11) 0.041*a
HDL(mmol/L) 1.07(1.01-1.17) 1.08(1.01-1.21) 0.98b
FFA(mmol/L) 0.40(0.40-0.51) 0.38(0.33-0.41) 0.047*b
CRP(mmol/L) 3.75(3.60-4.77) 4.30(4.05-5.11) 0.188b
Adiponectin(μg/ml) 5.26(5.09-7.61) 2.78(2.69-4.40) <0.001*b
Prostate volume(ml) 23.05(22.31-24.29) 45.04(46.66-63.61) <0.001*b
Qmax(ml/s) 25.65(24.97-27.74) 8.20(7.66-8.97) <0.001*a
Number (%) Number (%)
Categorical/Ordinal variables
BMI(kg/m2) † 0.009*c
 Underweight 3(6) 1(2.1)
 Normal 19(38) 6(12.5)
 Overweight 13(26) 13(27.1)
 Obesity 15(30) 28(58.3)
Adiponectin quartiles# <0.001*c
 Q1≤1.972 3(6) 21(43.8)
 1.97<Q2≤3.727 15(30) 10(20.8)
 3.727<Q3≤7.104 15(30) 10(20.8)
 Q4>7.104 17(34) 7(14.6)
IPSS <0.001*c
 None or light(0-7) 50(100) 0(0)
 Moderate(8-19) 0(0) 21(43.8)
 Severe(20-35) 0(0) 27(56.3)
Physical activity 0.024*c
 Sedentary 10(20) 21(43.8)
 Light 23(46) 19(39.6)
 Moderate 17(34) 8(16.7)
 Active 0(0) 0(0)
Smoking status 0.867c
 Current 20(40) 20(41.7)
 Former/Never 30(60) 28(58.3)
Alcohol using status 0.715c
 Current 18(36) 19(39.6)
 Former/Never 32(64) 29(60.4)

a Student’s T-test

b Mann-Whitney U-test

c χ2 test

† According to guidelines for the Asian Pacific population (International Association for the Study of Obesity, World Health Organization). Underweight, <18.5; normal, 18.5 to <23; at risk of obesity or overweight, 23 to<25; obesity, ≥25.

#Serum adiponectin levels were categorized in quartiles of its distribution.

*The significant parameters.

BPH, benign prostatic hyperplasia; BMI, body mass index; FPG, fasting plasma glucose; SBP, systolic blood pressure; DBP, diastolic blood pressure; PSA, prostatic specific antigen; LDL, low-density lipoprotein; HDL, high-density lipoprotein; CRP, C-reactive protein; Qmax, maximum flow rate; FFA, free fatty acid.